Correlation Between GM and Relief Therapeutics
Can any of the company-specific risk be diversified away by investing in both GM and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and Relief Therapeutics Holding, you can compare the effects of market volatilities on GM and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and Relief Therapeutics.
Diversification Opportunities for GM and Relief Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between GM and Relief is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of GM i.e., GM and Relief Therapeutics go up and down completely randomly.
Pair Corralation between GM and Relief Therapeutics
Allowing for the 90-day total investment horizon General Motors is expected to generate 0.42 times more return on investment than Relief Therapeutics. However, General Motors is 2.4 times less risky than Relief Therapeutics. It trades about -0.12 of its potential returns per unit of risk. Relief Therapeutics Holding is currently generating about -0.07 per unit of risk. If you would invest 5,499 in General Motors on September 20, 2024 and sell it today you would lose (384.00) from holding General Motors or give up 6.98% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
General Motors vs. Relief Therapeutics Holding
Performance |
Timeline |
General Motors |
Relief Therapeutics |
GM and Relief Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with GM and Relief Therapeutics
The main advantage of trading using opposite GM and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.The idea behind General Motors and Relief Therapeutics Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Relief Therapeutics vs. NRx Pharmaceuticals | Relief Therapeutics vs. NRX Pharmaceuticals | Relief Therapeutics vs. Pasithea Therapeutics Corp | Relief Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |